BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3592858)

  • 1. Perfluorochemical emulsion effect on warfarin binding by fraction V human albumin.
    Parsons DL
    Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):23-30. PubMed ID: 3592858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of warfarin by human albumin in the presence of a perfluorochemical blood substitute.
    Parsons DL; Ravis WR; Clark CR
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):4-14. PubMed ID: 4062432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a perfluorochemical emulsion on L-tryptophan binding by human albumin.
    Sathe RS; Parsons DL
    Arch Int Pharmacodyn Ther; 1990; 304():34-43. PubMed ID: 2241417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salicylate binding by human albumin in the presence of a perfluorochemical emulsion.
    Parsons DL; Sathe RS
    Arch Int Pharmacodyn Ther; 1991; 310():5-12. PubMed ID: 1772331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human albumin and alpha 1-acid glycoprotein binding of propranolol in the presence of a perfluorochemical blood substitute.
    Parsons DL; Shih RL
    Arch Int Pharmacodyn Ther; 1989; 297():294-304. PubMed ID: 2730240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of perfluorochemical emulsion components on human albumin binding of warfarin.
    Parsons DL; Nadkarni SR
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):165-74. PubMed ID: 3675079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfluorochemical emulsion effect on human albumin binding of valproic acid.
    Parsons DL; Ravis WR; Huang HC
    Res Commun Chem Pathol Pharmacol; 1991 Aug; 73(2):245-8. PubMed ID: 1784838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a perfluorochemical blood substitute on diazepam binding by human albumin.
    Graben RD; Parsons DL
    J Pharm Pharmacol; 1988 Oct; 40(10):684-8. PubMed ID: 2907533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human albumin binding of tamoxifen in the presence of a perfluorochemical erythrocyte substitute.
    Shah IG; Parsons DL
    J Pharm Pharmacol; 1991 Nov; 43(11):790-3. PubMed ID: 1686908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluorochemical erythrocyte substitutes: disposition and effects on drug distribution and elimination.
    Ravis WR; Hoke JF; Parsons DL
    Drug Metab Rev; 1991; 23(3-4):375-411. PubMed ID: 1935577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competition between serum albumin and soluble fraction of liver for binding of warfarin and other drugs.
    Wosilait WD; Ryan MP; Byington KH
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):113-21. PubMed ID: 7291718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    Kragh-Hansen U
    Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
    Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
    BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of urapidil to human serum albumin: dependency on free fatty acid concentration.
    Storck J; Kirsten R
    Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):204-8. PubMed ID: 2071271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of oleic acid, tolbutamide, and oxyphenbutazone on the binding of warfarin by human serum albumin.
    Wosilait WD; Ryan MP
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):577-84. PubMed ID: 504792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin metabolites: stereochemical aspects of protein binding and displacement by phenylbutazone.
    Chan E; McLachlan AJ; Rowland M
    Chirality; 1993; 5(8):610-5. PubMed ID: 8305289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intersubject variation of warfarin binding to protein in serum of normal subjects.
    Yacobi A; Stoll RG; DiSanto AR; Levy G
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):743-6. PubMed ID: 959669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of warfarin with human serum albumin. A stoichiometric description.
    Larsen FG; Larsen CG; Jakobsen P; Brodersen R
    Mol Pharmacol; 1985 Feb; 27(2):263-70. PubMed ID: 3969070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HSA affinity of warfarin and flurbiprofen determined by fluorescence anisotropy measurements of camptothecin.
    Wybranowski T; Cyrankiewicz M; Ziomkowska B; Kruszewski S
    Biosystems; 2008 Dec; 94(3):258-62. PubMed ID: 18721856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.